| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 35.550 | 170.411 | 89.934 | 57.749 | 77.992 |
| Total Income - EUR | - | - | - | - | - | 35.550 | 170.411 | 89.943 | 57.749 | 78.138 |
| Total Expenses - EUR | - | - | - | - | - | 36.685 | 161.333 | 80.779 | 58.592 | 76.850 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.135 | 9.079 | 9.164 | -842 | 1.289 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.135 | 7.545 | 8.399 | -1.333 | 195 |
| Employees | - | - | - | - | - | 2 | 4 | 2 | 2 | 2 |
Check the financial reports for the company - Pharma Zoo Vet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 40.450 | 53.278 | 53.934 | 71.074 | 128.904 |
| Inventories | - | - | - | - | - | 26.947 | 10.236 | 11.189 | 63.868 | 118.257 |
| Receivables | - | - | - | - | - | 12.042 | 41.953 | 41.713 | 6.309 | 9.292 |
| Cash | - | - | - | - | - | 1.461 | 1.089 | 1.031 | 898 | 1.355 |
| Shareholders Funds | - | - | - | - | - | -1.093 | 6.475 | 14.894 | 13.516 | 13.635 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 41.543 | 46.802 | 39.039 | 57.559 | 115.269 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Pharma Zoo Vet S.r.l.